| 1996 |
ANP32A (PHAP-I/I1PP2A) was identified as a potent heat-stable inhibitor of protein phosphatase 2A (PP2A), with half-maximal inhibition at ~4 nM, and did not affect PP1, PP2B, or PP2C activities. |
In vitro phosphatase activity assay using purified recombinant human PHAP-I against PP2A, PP1, PP2B, PP2C |
Biochemistry |
High |
8679524
|
| 2002 |
ANP32A (pp32) is a subunit of the INHAT (inhibitor of acetyltransferases) complex and inhibits histone acetyltransferase (HAT) activity of p300/CBP and PCAF by masking histones; its INHAT domains mediate histone binding, HAT inhibition, and transcriptional repression in vivo. |
In vitro HAT inhibition assays, colocalization and transfection studies, deletion/domain analysis |
The Journal of biological chemistry |
High |
11830591
|
| 2004 |
ANP32A (pp32/Set-TAF-Ibeta) specifically binds to unacetylated and hypoacetylated histones but not hyperacetylated histones, associates with histone deacetylases in vitro and in vivo, and associates with an endogenous estrogen receptor-regulated gene (EB1) in the hypoacetylated transcriptionally inactive state but not in the active state. |
Histone binding assays, co-immunoprecipitation with HDACs, chromatin immunoprecipitation at endogenous gene |
The Journal of biological chemistry |
High |
15136563
|
| 2008 |
ANP32A (PHAPI) promotes apoptosome formation by working together with CAS and Hsp70 to accelerate nucleotide exchange on Apaf-1 and prevent inactive Apaf-1/cytochrome c aggregation, thereby enhancing caspase-9 activation. |
Biochemical reconstitution of apoptosome activity, identification of CAS and Hsp70 as co-mediators, siRNA knockdown in cells measuring Apaf-1 aggregation and apoptosis |
Molecular cell |
High |
18439902
|
| 2008 |
ANP32A (pp32/PHAP-I) promotes cytoplasmic translocation of HuR upon lethal stress; in the cytoplasm, ANP32A facilitates caspase-mediated cleavage of HuR at Asp226, amplifying the apoptotic response. siRNA depletion of ANP32A reduces both HuR cytoplasmic accumulation and caspase activation efficiency. |
siRNA knockdown, co-immunoprecipitation, HuR cleavage assays, non-cleavable mutant (D226A) overexpression |
The Journal of cell biology |
High |
18180367
|
| 2008 |
ANP32A (I1PP2A) interacts specifically with the catalytic subunit of PP2A (PP2Ac) but not with regulatory A or B subunits; the N-terminal isotype-specific region of ANP32A is required for PP2Ac association and PP2A inhibition. Overexpression of ANP32A in PC12/Tau441 cells increases Tau phosphorylation and impairs microtubule network and neurite outgrowth. |
GST pulldown, co-immunoprecipitation from transfected cells, deletion mutagenesis, in vitro phosphatase assay, immunofluorescence |
The Journal of biological chemistry |
High |
18245083
|
| 2004 |
ANP32A (pp32) directly binds to casein kinase II (CKII), which phosphorylates pp32 at serines 158 and 204 in vivo. Mutagenesis of these sites affects pp32 function. |
In vitro kinase assay, biochemical purification, deletion and site-directed mutagenesis, phospho-specific antibody validation |
Biochemistry |
High |
15287743
|
| 2016 |
Species-specific differences in ANP32A account for the suboptimal activity of avian influenza polymerase in mammalian cells. Avian ANP32A has an additional 33 amino acids between the LRR and LCAR domains; deletion of this insertion abrogates support of avian polymerase, and its insertion into human ANP32A rescues avian virus polymerase function. ANP32A is an essential host partner co-opted to support influenza virus replication. |
Rescue experiments with avian ANP32A in mammalian cells, deletion and insertion mutagenesis, influenza polymerase activity assays |
Nature |
High |
26738596
|
| 2020 |
Cryo-EM structures of influenza C virus polymerase in complex with human and chicken ANP32A reveal that two FluPol molecules form an asymmetric dimer bridged by the N-terminal LRR domain of ANP32A, while the C-terminal LCAR of ANP32A inserts between the two juxtaposed PB2 627 domains, providing a structural mechanism for how PB2(E627K) enables mammalian adaptation. |
Cryo-electron microscopy structure determination of FluPolC–ANP32A complexes |
Nature |
High |
33208942
|
| 2015 |
ANP32A (pp32) and ANP32B (APRIL) constitute host-derived IREF-2 activity that interacts with free viral RNA-dependent RNA polymerase and preferentially upregulates vRNA synthesis from cRNA templates. Knockdown of these proteins reduces viral replication in vivo. |
Biochemical complementation assay with nuclear extracts, protein identification by mass spectrometry, siRNA knockdown |
eLife |
High |
26512887
|
| 2020 |
NMR analysis of PB2 627-NLS domains in complex with avian and human ANP32A shows that human ANP32A IDD transiently binds the 627 domain via multivalent interactions; PB2-E627 disrupts polyvalency of this interaction, an effect compensated by the avian-unique 33-aa motif in avian ANP32A IDD. |
NMR spectroscopy, conformational ensemble determination of PB2 627-NLS/ANP32A complexes |
Nature communications |
High |
32694517
|
| 2004 |
Tyrosine phosphorylation of ANP32A (PHAPI/pp32) by jacalin stimulation releases PP2A from ANP32A inhibition, thereby activating PP2A and leading to dephosphorylation of MEK1/2 and ERK1/2. PHAPI knockdown by RNAi abolished both PP2A activation and MEK inhibition by jacalin. |
Immunoprecipitation kinase assays, PP2A activity assay, siRNA knockdown, Western blot of MEK/ERK phosphorylation |
The Journal of biological chemistry |
High |
15247276
|
| 2000 |
ANP32A (I1PP2A) associates with the catalytic subunit of PP1 in the presence of Mn2+ and modifies its substrate specificity, stimulating PP1 activity toward myelin basic protein and histone H1 (but not phosphorylase) by 15–20 fold, an activity not seen with Co2+, Mg2+, Ca2+, or Zn2+. |
In vitro phosphatase activity assay, gel filtration co-elution with Mn2+, recombinant proteins |
The Journal of biological chemistry |
High |
10734057
|
| 2007 |
Crystal structure of the N-terminal LRR domain of pp32 (ANP32A) was determined, revealing a capped leucine-rich repeat fold that mediates protein-protein interactions characteristic of the ANP32 family. |
X-ray crystallography |
Protein science |
High |
17567741
|
| 2005 |
ANP32A (pp32/LANP) interacts with adenovirus E4orf6, which exports pp32 from the nucleus to the cytoplasm along with HuR; this complex stabilizes ARE-containing mRNAs (c-fos, c-myc, COX-2) in the cytoplasm via a CRM1-independent mechanism. |
Co-immunoprecipitation, subcellular fractionation, mRNA stability assays, CRM1 inhibitor (leptomycin B) experiments |
The Journal of cell biology |
Medium |
15983058
|
| 2005 |
Adenovirus protein VII associates with ANP32A (pp32) and SET in vitro, with distinct protein VII domains responsible for binding each; protein VII, ANP32A, and SET co-associate with viral DNA during early infection. |
In vitro binding assays, chromatin immunoprecipitation, immunofluorescence |
Journal of virology |
Medium |
15681448
|
| 2007 |
ANP32A (LANP) forms a complex with transcriptional repressor E4F and modulates its repressive activity; ataxin-1 competes with E4F for LANP binding, relieving LANP-E4F-mediated transcriptional repression. This links ANP32A to SCA1 pathology. |
Co-immunoprecipitation, transcriptional reporter assays, competition binding experiments |
EMBO reports |
Medium |
17557114
|
| 2005 |
ANP32A (pp32) tumor suppression requires amino acids 150–174; deletion or truncation of this region abolishes inhibition of oncogene-mediated (RAS+MYC) transformation in rat embryo fibroblasts. The oncogenic pp32r1 and pp32r2 differ from pp32 precisely in this region. |
Deletion and truncation mutagenesis, rat embryo fibroblast transformation assays (focus formation, soft agar) |
The Journal of biological chemistry |
Medium |
10400610
|
| 2005 |
Hyperphosphorylated Rb interacts with ANP32A (pp32) but not with closely related pp32r1 or pp32r2; this Rb-pp32 interaction inhibits the apoptotic activity of pp32 and stimulates cell proliferation. |
Co-immunoprecipitation, apoptosis functional assays, proliferation assays |
The Journal of biological chemistry |
Medium |
15716273
|
| 2009 |
ANP32A (PHAPI) apoptotic activity—stimulation of caspase activation via the apoptosome—is required for its tumor suppressive function. The PHAPI close homolog pp32R1 (an oncoprotein) cannot stimulate caspase activation; the critical difference maps to amino acids in the caspase activation motif. ANP32A translocates from nucleus to cytoplasm during apoptosis; disruption of its NLS modestly decreases tumor suppression. |
Truncation mutagenesis, in vitro caspase activation assay, subcellular fractionation, tumor suppression assays |
The Journal of biological chemistry |
Medium |
19121999
|
| 2010 |
Sphingosine (and DMS, phytosphingosine) directly binds ANP32A identified by affinity chromatography/proteomics; sphingoid base binding relieves ANP32A-mediated PP2A inhibition in vitro and activates PP2A in endothelial cells, leading to p38 SAPK activation and COX-2 induction. ANP32A siRNA knockdown enhanced basal and DMS-activated PP2A activity. |
Affinity chromatography with sphingosine, proteomics, in vitro PP2A activity assay, siRNA knockdown |
The Journal of biological chemistry |
Medium |
20558741
|
| 2009 |
ANP32A (LANP) depletion promotes neurite outgrowth in neuronal cell lines and primary neurons from LANP null mice; LANP directly binds the neurofilament light chain (NF-L) gene promoter and suppresses histone acetylation at this locus, repressing NF-L expression. |
siRNA knockdown in neuronal cell lines, primary neuron culture from LANP KO mice, ChIP at NF-L promoter, histone acetylation analysis |
The Journal of biological chemistry |
Medium |
19136565
|
| 2011 |
ANP32A (pp32) interacts with STAT1 and STAT2 in an IFN-dependent manner and is required for maximal transcriptional induction of IFN-stimulated genes (ISGs) by promoting assembly of transcription initiation complexes at ISG promoters; siRNA knockdown of pp32 reduces histone acetylation on ISG promoters. |
Co-immunoprecipitation (IFN-dependent), ChIP at ISG promoters, siRNA knockdown with IFN-stimulated gene expression readout |
Journal of cell science |
Medium |
21325029
|
| 2017 |
ANP32A (PP32) and SET/TAF-Iβ are components of the newly synthesized histone H4 complex identified by proteomics; they function to prevent HAT1-mediated acetylation of H4K5 and H4K12 in vitro. Depletion of PP32 and SET/TAF-Iβ causes hyperacetylation of H4 lysine residues, destabilizes H4-Hsp90 interaction, and results in S-phase arrest. |
Proteomic analysis of newly synthesized H4 complex, in vitro HAT inhibition assay, siRNA knockdown with histone acetylation and cell cycle analysis |
Nucleic acids research |
Medium |
28977641
|
| 2010 |
ANP32A (pp32) overexpression in pancreatic cancer cells reduces HuR association with mRNAs encoding dCK, VEGF, and HuR itself; silencing pp32 enhances HuR binding to these mRNA targets, affecting gemcitabine sensitivity through altered dCK protein levels. |
RNA immunoprecipitation (RIP), overexpression and siRNA knockdown, mRNA binding assays, gemcitabine sensitivity assays |
PloS one |
Medium |
21152064
|
| 2018 |
ANP32A deficiency in AML cells reduces genome-wide histone H3 acetylation, with significant H3 acetylation changes at lipid metabolism genes (APOC1, PCSK9, P2RX1, LPPR3); overexpression of APOC1 partially rescues the proliferation defect of ANP32A-deficient AML cells. |
Genome-wide ChIP-seq for H3 acetylation, gene expression analysis, APOC1 overexpression rescue experiment |
Leukemia |
Medium |
29467488
|
| 2018 |
ANP32A protects cartilage against oxidative stress and OA by promoting expression of ATM (a key cellular oxidative defense regulator); Anp32a-deficient mice show reduced ATM expression and develop OA, osteopenia, and cerebellar ataxia, all rescued by antioxidant treatment. |
Microarray profiling in Anp32a KO mice, in vivo OA model, antioxidant treatment, immunohistochemistry |
Science translational medicine |
Medium |
30209244
|
| 2019 |
ANP32A and ANP32B mediate nuclear export of unspliced/partially spliced HIV-1 mRNA via interactions with Rev and CRM1; double (but not single) knockout of ANP32A and ANP32B accumulates unspliced viral mRNA in the nucleus and reduces Gag protein expression; reconstitution of either restores viral production. |
Double knockout, RNA nuclear/cytoplasmic fractionation, co-immunoprecipitation with Rev and CRM1, Gag expression assay |
The Journal of biological chemistry |
Medium |
31444273
|
| 2019 |
Human ANP32A or ANP32B alone is indispensable for human influenza A virus RNA replication; two amino acids at positions 129–130 of chicken ANP32B are responsible for its inability to support viral replication and its weak interaction with the viral polymerase complex. |
siRNA/KO of ANP32A and ANP32B, polymerase activity reporter assays, co-immunoprecipitation, site-directed mutagenesis |
Journal of virology |
Medium |
30996088
|
| 2020 |
Swine ANP32A uniquely (among mammalian ANP32 proteins) supports avian influenza polymerase activity; this is mapped to amino acids 106V and 156S in swANP32A. Mutation of these residues weakens interaction with chicken viral polymerase and reduces polymerase activity. ANP32A knockout in pig (PK15) cells dramatically reduces avian influenza polymerase activity. |
Polymerase activity reporter assays, site-directed mutagenesis, co-immunoprecipitation, ANP32A knockout in pig cells |
PLoS pathogens / Journal of virology |
Medium |
32084248 32269123
|
| 2017 |
Downregulating ANP32A in hippocampal CA3 of tau transgenic mice rescues memory loss and synaptic deficits by reducing INHAT complex formation and unmasking histones for acetylation; ANP32A levels are upregulated by tau accumulation, β-amyloid, and H2O2 via C/EBPβ activation. |
Lentiviral shRNA stereotaxic injection, Morris water maze, electrophysiology, Golgi staining, ChIP, Western blot |
Molecular neurodegeneration |
Medium |
28472990
|
| 2022 |
ANP32A represses Wnt signaling in articular cartilage via histone acetylation masking; ANP32A co-immunoprecipitates with components at Wnt target gene loci, and its loss triggers Wnt hyper-activation and cardiac hypertrophy. Combined antioxidant and Wnt inhibitor treatment ameliorates OA in Anp32a-deficient mice. |
Co-immunoprecipitation, ChIP-qPCR, luciferase assays, Anp32a KO mouse DMM OA model, Wnt inhibitor/antioxidant treatment |
Osteoarthritis and cartilage |
Medium |
35227892
|
| 2004 |
ANP32A (pp32) specifically binds to histone H3 and blocks both its acetylation and phosphorylation; pp32 overexpression inhibits cell growth in Jurkat T cells and directly initiates caspase activity and promotes granzyme A-mediated caspase-independent cell death. |
Histone binding assays, histone acetylation/phosphorylation analysis, caspase activity assay, cell growth assays |
Cell death and differentiation |
Medium |
16341127
|
| 2006 |
ANP32A (LANP/I1PP2A) is pulled down by the cytoplasmic domain of integrin α3A and co-localizes with integrin α3β1; GST-ANP32A pulls down both integrin α3β1 and PP1 from cell lysates, and PP1 can dephosphorylate integrin α3β1 at T1046 in vitro, suggesting ANP32A bridges PP1 and integrin α3β1. |
Affinity chromatography, GST pulldown, co-localization by immunofluorescence, in vitro phosphatase assay |
Journal of neuroscience research |
Low |
17016859
|
| 2008 |
The NMR solution structure of the ANP32A LRR domain was determined; the LRR domain interacts with the AXH domain of ataxin-1 with millimolar (very weak) affinity, suggesting additional partners or post-translational modification is needed for stable binding. Two-hybrid screening identified Clip-170/Restin as a new LRR domain partner. |
NMR spectroscopy, yeast two-hybrid screening, in vitro binding assay |
The FEBS journal |
Medium |
18410380
|
| 2017 |
Direct species-independent interactions exist between all ANP32A splice variants and the PB2 polymerase subunit; this interaction is enhanced in the presence of viral genomic RNA. However, only avian ANP32A (containing the 33-aa or 29-aa insertion) restored RNP complex assembly and enhanced RNA synthesis for a restricted polymerase. |
Split luciferase complementation assays, co-immunoprecipitation, influenza minigenome assays |
Cell reports |
Medium |
30184493
|
| 2020 |
Human ANP32A interacts weakly with influenza polymerase; the 33-aa insertion of avian ANP32A and a hydrophobic SIM-like sequence unique to avian ANP32A both promote stronger polymerase interaction. SUMOylation of the host cell contributes to vPol activity including avian ANP32A function. |
Split luciferase complementation, co-immunoprecipitation, in situ split Venus interaction, mutagenesis, SUMO pathway manipulation |
Cell reports |
Medium |
28903035
|
| 2021 |
ANP32A is required for both vRNA and cRNA synthesis by the influenza A virus polymerase (not just vRNA from cRNA as previously proposed); ANP32A is needed for the actively replicating polymerase but not the encapsidating polymerase. |
Minigenome assays with ANP32A knockout/rescue, virus infection studies, viral promoter mutations |
Journal of virology |
Medium |
34935435
|
| 2013 |
ANP32A (LANP/pp32) interacts with LIM-homeodomain transcription factor LHX3 via the LHX3 carboxyl terminus; LANP is associated with LHX3 target genes in pituitary cells (by ChIP), and experimental alteration of LANP levels affects LHX3-mediated pituitary gene regulation. |
Mass spectrometry, biochemical domain mapping, co-immunoprecipitation, ChIP, gain/loss-of-function transcription assays |
PloS one |
Medium |
23861948
|
| 2024 |
Human ANP32A is SUMOylated at K68 and K153 by the E3 SUMO ligase PIAS2α and deSUMOylated by SENP1; SUMOylated ANP32A recruits influenza NS2 via a SIM-SUMO interaction, facilitating ANP32A-supported avian polymerase activity and vRNP-ANP32A interactions. |
SUMOylation assays, mutagenesis of SUMOylation sites, co-immunoprecipitation, vRNP assembly assays, PIAS2α/SENP1 manipulation |
Nature communications |
Medium |
39737943
|
| 2023 |
NMR characterization of ternary complexes shows avian ANP32A simultaneously binds influenza FluPol and NP via distinct linear motifs in its longer disordered domain; the 33-aa deletion in human ANP32A blocks this simultaneous colocalization. PB2-E627K mutation enables FluPol and NP to bind the same extended linear motif on human ANP32A in a highly dynamic multivalent ternary complex. |
NMR spectroscopy of ternary FluPol/NP/ANP32A complexes, interaction mapping |
Journal of the American Chemical Society |
High |
37707433
|
| 2022 |
AIMP1 interacts with ANP32A (identified by protein chip assay) and this interaction regulates histone H3 acetylation in multiple myeloma cells; disruption of AIMP1 expression reduces H3 acetylation enrichment at GAREM2 locus and decreases ERK1/2 phosphorylation. |
Protein chip assay, co-immunoprecipitation, ChIP-seq, siRNA knockdown |
Cancer communications |
Low |
36042007
|
| 2004 |
ANP32A (pp32) overexpression suppresses Raf-1 activation, downregulating ERK activation; the C-terminal half of pp32 is required for Raf-1 suppression. siRNA knockdown of pp32 enhances ERK and MEK activation. |
Overexpression and siRNA knockdown, Western blot of Raf-1/MEK/ERK phosphorylation, deletion mutagenesis |
Cancer letters |
Low |
16039954
|
| 2015 |
Cranial high-resolution X-ray crystal structure of the ANP32A LRR domain was determined at 1.56 Å, showing displacement in the turn connecting α1 to β1 compared to prior 2.4/2.69 Å structures. |
X-ray crystallography at 1.56 Å resolution |
Acta crystallographica Section F |
Medium |
26057796
|
| 2021 |
ANP32A binds HMGA1 mRNA via RNA immunoprecipitation and maintains HMGA1 mRNA stability, thereby promoting HMGA1 protein expression and subsequent STAT3 activation in hepatocellular carcinoma cells. |
RNA immunoprecipitation (RIP), siRNA knockdown and overexpression, Western blot, xenograft model |
Carcinogenesis |
Low |
33332531
|